3.9(top 4%)
Impact Factor
4.2(top 4%)
extended IF
74(top 5%)
H-Index
1.5K
authors
2.9K
papers
41.6K
citations
3.9K
citing journals
23.6K
citing authors

Most Cited Articles of Cardiovascular Drugs and Therapy

TitleYearCitations
Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study2005843
Anthracycline Chemotherapy and Cardiotoxicity2017418
Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival--41997365
Elastic properties and Windkessel function of the human aorta1995265
Necrostatin: a potentially novel cardioprotective agent?2007251
Phospholipase A2 biochemistry2009249
The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study2001248
Oxygen-derived free radicals and myocardial reperfusion injury: an overview1991221
Oxidized LDL, LOX-1 and atherosclerosis2011215
Nicotine and sympathetic neurotransmission1997184
SGLT-2 Inhibition with Dapagliflozin Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Cardiomyopathy in Mice with Type 2 Diabetes. Further Augmentation of the Effects with Saxagliptin, a DPP4 Inhibitor2017165
Grape resveratrol increases serum adiponectin and downregulates inflammatory genes in peripheral blood mononuclear cells: a triple-blind, placebo-controlled, one-year clinical trial in patients with stable coronary artery disease2013159
A single bolus of a long-acting erythropoietin analogue darbepoetin alfa in patients with acute myocardial infarction: a randomized feasibility and safety study2006156
"Escape" of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: implications for therapy1995156
Biology of platelet-activating factor acetylhydrolase (PAF-AH, lipoprotein associated phospholipase A2)2009155
Mechanism of cardioprotection by early ischemic preconditioning2010153
The cardioprotective effect of necrostatin requires the cyclophilin-D component of the mitochondrial permeability transition pore2007136
Cardiac sarcoidosis: diagnostic, prognostic, and therapeutic considerations1996126
Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia and LDL-C of 160 mg/dl or Higher2016125
The interplay between pro-death and pro-survival signaling pathways in myocardial ischemia/reperfusion injury: apoptosis meets autophagy2006122
Comparison of trimetazidine with nifedipine in effort angina: a double-blind, crossover study1990121
Intima media thickness as a surrogate marker for generalised atherosclerosis2002120
The second window of preconditioning (SWOP) where are we now?2010117
Improvement in endothelial progenitor cells from peripheral blood by ramipril therapy in patients with stable coronary artery disease2004115
Hypolipidemic and antioxidant effects of Commiphora mukul as an adjunct to dietary therapy in patients with hypercholesterolemia1994115